Safety and immunogenicity of sars-cov-2 vaccine mvc-cov1901 in taiwanese adolescents: a randomized phase 2 trial

HIGHLIGHTS

• who: Luke Tzu-Chi Liu from the Study design and participants This is an interim analysis of an ongoing phase, prospective, double-blind (investigator/site staff and participants), and multicenter study to assess the safety and immunogenicity of , in adolescents aged, yearsThe study sites included five hospitals/medical centers in Taiwan. Eligible participants were those aged , (inclusive) to , at the time of randomization, with BMI at or above the third percentile according to World Health Organization (WHO) at the screening visit, and lack of travel within , days of screening and lack of any oversea traveling throughout the . . .
  

   

  

  If you want to have access to all the content you need to log in!

  Thanks :)

  Username or E-mail:

  If you don't have an account, you can create one here.